- Home
- CNXN vs VCEL Comparison
CNXN vs VCEL Comparison
Compare CNXN & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNXN
- VCEL
- Stock Information
- Founded
- CNXN 1982
- VCEL 1989
- Country
- CNXN United States
- VCEL United States
- Employees
- CNXN N/A
- VCEL N/A
- Industry
- CNXN Catalog/Specialty Distribution
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CNXN Consumer Discretionary
- VCEL Health Care
- Exchange
- CNXN Nasdaq
- VCEL Nasdaq
- Market Cap
- CNXN 1.6B
- VCEL 1.6B
- IPO Year
- CNXN 1998
- VCEL 1997
- Fundamental
- Price
- CNXN $60.97
- VCEL $35.06
- Analyst Decision
- CNXN
- VCEL Strong Buy
- Analyst Count
- CNXN 0
- VCEL 6
- Target Price
- CNXN N/A
- VCEL $58.60
- AVG Volume (30 Days)
- CNXN 74.6K
- VCEL 578.6K
- Earning Date
- CNXN 10-29-2025
- VCEL 11-06-2025
- Dividend Yield
- CNXN 0.98%
- VCEL N/A
- EPS Growth
- CNXN N/A
- VCEL 2045.40
- EPS
- CNXN 3.24
- VCEL 0.13
- Revenue
- CNXN $2,878,704,000.00
- VCEL $249,119,000.00
- Revenue This Year
- CNXN $7.92
- VCEL $18.35
- Revenue Next Year
- CNXN $5.82
- VCEL $22.26
- P/E Ratio
- CNXN $18.82
- VCEL $262.52
- Revenue Growth
- CNXN 3.19
- VCEL 16.13
- 52 Week Low
- CNXN $55.50
- VCEL $29.24
- 52 Week High
- CNXN $75.84
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- CNXN 46.24
- VCEL 51.82
- Support Level
- CNXN $56.06
- VCEL $35.47
- Resistance Level
- CNXN $62.56
- VCEL $36.99
- Average True Range (ATR)
- CNXN 1.33
- VCEL 1.52
- MACD
- CNXN -0.02
- VCEL -0.01
- Stochastic Oscillator
- CNXN 68.86
- VCEL 52.81
About CNXN PC Connection Inc.
PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.